| ²é¿´: 282 | »Ø¸´: 0 | ||
Paul-DingÌú³æ (³õÈëÎÄ̳)
|
[ÇóÖú]
CTONG1002
|
| CTONG1002 ÐèҪȫÎÄ£¬¼±Çó£¬Ð»Ð»£¡A phase II trial of first-line nab-paclitaxel/carboplatin versus gemcitabine/carboplatin in advanced squamous cell carcinoma of the lung (CTONG1002). |
» ²ÂÄãϲ»¶
339·Ö»¤Àí¿¼ÉúÉêÇëµ÷¼ÁµÄ×Ô¼öÐÅ
ÒѾÓÐ0È˻ظ´
ÉÏ º£ ½» ´ó ¿É ½µ ½â Éú Îï ²Ä ÁÏ ×é Äâ ÕÐ 24 Äê ÆÕ ²© Éú 1 Ãû£¨4 . 10 ǰ£©
ÒѾÓÐ3È˻ظ´
ҽѧ²¡Ô΢ÉúÎïÓë¸ÐȾÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ193È˻ظ´
ÉÏ º£ ½» ´ó ¿É ½µ ½â Éú Îï ²Ä ÁÏ ×é Äâ ÕÐ 24 Äê ÆÕ ²© Éú 1 Ãû£¨4.10ǰ£©
ÒѾÓÐ0È˻ظ´
ÉϺ£½»Í¨´óѧ²ÄÁÏ¿ÆÑ§Ó빤³ÌѧԺÄâÕÐÊÕ2025ÄêÑо¿ÉúÁ½Ãû
ÒѾÓÐ0È˻ظ´
ÇóÖúÒÀÌæÃ×ÐÇ£¬ÄÎÌæÃ×ÐÇ£¬ÒìÅÁÃ×ÐǵݬÃÀÊËÊý¾Ý
ÒѾÓÐ0È˻ظ´













»Ø¸´´ËÂ¥
5